As part of its ongoing efforts to streamline regulatory processes and ensure better clarity for applicants, the Health Sciences Authority...

As the digital health landscape continues to evolve rapidly, the Health Sciences Authority (HSA) released the Revision 2 (R2)  of its...

The Health Sciences Authority (HSA) has announced the implementation of revised GN-21, which is set to take effect on 14 July 2025 . This...

The Health Sciences Authority (HSA) is ushering in a new era for the medical device industry with the launch of the Singapore Health...

The Health Sciences Authority (HSA) launched a public consultation on a pivotal proposal that could significantly reshape the landscape...

The landscape of clinical research is constantly evolving, and with it, the standards that ensure trial integrity and participant safety...

The Health Sciences Authority (HSA) is set to roll out a significant update to its regulatory infrastructure with the Singapore Health...

The increasing integration of technology in healthcare has revolutionized patient care and introduced new cybersecurity challenges. As...

The Health Sciences Authority (HSA) is excited to announce the launch of SHARE (Singapore Health Product Access and Regulatory E-System)...

Singapore's Health Sciences Authority (HSA) is taking a significant step toward modernizing regulatory frameworks with its pilot for the...

On 16 October 2024, the Cybersecurity Labelling Scheme for Medical Devices (CLS [MD]) was officially launched, following a successful...

The Health Sciences Authority (HSA) of Singapore released regulatory updates at the end of September 2024. The updates involve...

The Therapeutic Products Branch (TPB) of the Health Science Authority (HSA) has announced the latest updates on regulatory procedures, as...

“NextGen MD Initiative” was introduced by the Health Sciences Authority (HSA) on 13 June 2024 to facilitate the registration of...

HSA has set up a provisional authorisation process for tests intended for the detection and/or diagnosis of COVID-19 infection, to...

COVID-19 Diagnostic Test kits To address the urgent need for timely detection of COVID-19 infection, HSA has set up a provisional...

With increased surveillance on local e-commerce platforms and retail shops, over 1700 product listings have been removed for making false...

Singapore Industry is preparing for Product, Importer/Wholesaler Licence with GDPMDS compliance where HSA is looking at transition period...

Health Sciences Authority (HSA) has finalized the specific requirements for registration of Next Generation Sequencing based In-vitro...

With effect from 12 Feb 2020, two new chemicals adopted for listing under Annex A of the Stockholm Convention (SC) will be controlled as...